mir-433 (fold change of −9,6) is activated by the estrogen receptor ESRRG, in which several SNPs have been associated with higher risk of type 2 diabetes by GWAS [46] and that acts as a co-activator of the demethylating enzyme Dnmt1 [47]. This evidence concerns the gene ESRRG and type 2 diabetes mellitus.